Novartis buys into bispecific antibodies with Xencor deal
Agreement could add to Novartis’ immuno-oncology pipeline.
X
Novartis buys into bispecific antibodies with Xencor deal
https://pharmaphorum.com/news/novartis-signs-150m-antibody-deal-xencor/
Agreement could add to Novartis’ immuno-oncology pipeline.